A comparison of displacement and reinforcer potency for typically developing children
Adam B Carter1, Kimberley L M Zonneveld1
1Brock University.
Abstract:
Previous researchers found that individuals with intellectual and developmental disabilities tend to prefer edible over leisure stimuli, although leisure stimuli may still function as reinforcers. We replicated and extended previous research in a 2-part experiment with typically developing children. In Experiment 1, we evaluated 15 children's preference for leisure and edible stimuli. Five of 15 participants preferred edible over leisure stimuli, 3 of 15 participants preferred leisure over edible stimuli, and the remaining 7 of 15 participants did not show a preference for a stimulus class. In Experiment 2, we compared the reinforcer potency of the top-ranked stimulus from each class with 7 of the 8 participants who showed displacement of one stimulus class. Four of 7 participants allocated more responding to the task associated with the top-ranked stimulus and 3 of 7 participants showed no differences in responding to the task regardless of the stimulus rank.
Related Concept Videos
10:11Portable Intermodal Preferential Looking (IPL): Investigating Language Comprehension in Typically Developing Toddlers and Young Children with Autism
11:50EEG Mu Rhythm in Typical and Atypical Development
Metacognitive Development: How Children Estimate Their Memory
Human memory is fallible, and people often cannot accurately recall what they have seen or heard. Adults are aware of their limited memory capacity, so they use strategies, such as rehearsal and mnemonic devices, to improve their recall of important information. Because adults understand the limits of memory, they know it makes more sense to write down the items on their shopping list rather than to try...
14:15Measurement Of Neuromagnetic Brain Function In Pre-school Children With Custom Sized MEG
08:00Studying Brain Function in Children Using Magnetoencephalography
16:07Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method

